BANAN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Banan, and what generic alternatives are available?
Banan is a drug marketed by Sankyo and is included in two NDAs.
The generic ingredient in BANAN is cefpodoxime proxetil. There are ten drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the cefpodoxime proxetil profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Banan
A generic version of BANAN was approved as cefpodoxime proxetil by AUROBINDO PHARMA LTD on June 8th, 2007.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BANAN?
- What are the global sales for BANAN?
- What is Average Wholesale Price for BANAN?
Summary for BANAN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 51 |
Patent Applications: | 2,093 |
DailyMed Link: | BANAN at DailyMed |
US Patents and Regulatory Information for BANAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sankyo | BANAN | cefpodoxime proxetil | FOR SUSPENSION;ORAL | 050688-002 | Aug 7, 1992 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Sankyo | BANAN | cefpodoxime proxetil | TABLET;ORAL | 050687-002 | Aug 7, 1992 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Sankyo | BANAN | cefpodoxime proxetil | FOR SUSPENSION;ORAL | 050688-001 | Aug 7, 1992 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Sankyo | BANAN | cefpodoxime proxetil | TABLET;ORAL | 050687-001 | Aug 7, 1992 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |